Publications in collaboration with researchers from University Hospital of Zurich (12)

2025

  1. Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries

    Arthritis Research and Therapy, Vol. 27, Núm. 1

  2. Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

    Health Policy, Vol. 156

  3. Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis

    Joint Bone Spine, Vol. 92, Núm. 3

  4. Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study

    BMC Rheumatology, Vol. 9, Núm. 1

  5. Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network

    Journal of Rheumatology, Vol. 52, Núm. 6, pp. 572-582

  6. Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

    Rheumatology, Vol. 64, Núm. 4, pp. 1853-1863

2024

  1. Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

    RMD Open, Vol. 10, Núm. 3

  2. Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: A survey

    Rheumatology Advances in Practice, Vol. 8, Núm. 4

  3. Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

    Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892

2023

  1. Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  2. Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

    The Lancet Regional Health - Europe, Vol. 33

  3. Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

    RMD Open, Vol. 9, Núm. 4